🙋‍♂️ Raise your hand if you’re coming to #PsychUpdate27
Treatment-resistant cases aren’t getting easier—your strategy should get sharper
From mood disorders to ADHD to psychosis—this is where clinicians come to solve the cases that don’t follow the rules
Register now 👉 mdsc.pe/4deDOxW..
Don't let partial treatment responses leave your patients stranded.
Learn how to leverage a well-tolerated first-line platform and build an effective, combined strategy for residual symptoms.
Catch up on Episode 1 ➡️ mdsc.pe/4dLwjh6#Depression#Psychiatry#CME
🧠Psychiatry is changing—fast. From psychedelics to next-gen treatments, get the insights shaping real-world care.📍 mdsc.pe/4vH46Ag#PsychPharm26
🙋‍♂️ Raise your hand if you’re coming to #PsychUpdate27
Treatment-resistant cases aren’t getting easier—your strategy should get sharper
From mood disorders to ADHD to psychosis—this is where clinicians come to solve the cases that don’t follow the rules
Register now 👉 mdsc.pe/4deDOxW..
🚨 When standard treatments fail, guesswork isn’t enough
Explore structured, evidence-based approaches to complex psychiatric care
👉 Challenge your thinking 🔗 mdsc.pe/41GEJRd#PsychPharm26
🎓 Learn from leaders shaping modern psychiatry. From complex cases to evolving therapies—including psychedelics—gain insights you can apply immediately
👉 Access expert insight: mdsc.pe/41GEJRd#PsychPharm26
Managing depression after a first-line therapy fails starts with a critical decision.
Experts break down the core clinical rules for when you should switch a patient's strategy versus when to add an adjunct.
Watch the full episode ➡️ mdsc.pe/4dLwjh6#Depression#Psychiatry#CME
đź’¬ Bring your toughest cases
Get real answers from experts tackling complex psychiatric conditions
👉 Ask what matters 🔗 mdsc.pe/41GEJRd#PsychPharm26
🔬 What’s actually next in psychopharmacology?
Explore treatment advances, emerging therapies and the latest data!
👀 See what’s coming by clicking here:📍 bit.ly/4rrN7yN#PsychPharm26
🎓 Learn from leaders shaping modern psychiatry. From complex cases to evolving therapies—including psychedelics—gain insights you can apply immediately
👉 Access expert insight: mdsc.pe/41GEJRd#PsychPharm26
Starting in 1 HOUR ➡️ mdsc.pe/4udkh70
Care for depression is evolving. Join our live expert exchange with Dr. Harding, Dr. Thase, and Dr. Singh to explore the future of rapid-acting agents and closing the gap in patient recovery.
#Depression#Psychiatry#CME
LIVE TOMORROW: Navigate the evolving landscape of depression management. ➡️ mdsc.pe/4udkh70
Don't miss our clinical deep dive into novel interventions for residual symptoms with our expert panel. See you there!
🗓️ May 27th
⏰ 2:30pm ET
#MIND#Depression#MedicalEducation
🚨 When standard treatments fail, guesswork isn’t enough
Explore structured, evidence-based approaches to complex psychiatric care
👉 Challenge your thinking 🔗 mdsc.pe/41GEJRd#PsychPharm26
Waiting 4-6 weeks for an antidepressant to work isn't always an option for high-risk patients.
Explore new mechanisms of action with rapid onset data that are changing the algorithm for difficult-to-treat depression.
Watch the full breakdown ➡️ x.com/i/broadcasts/1yKAPMoOv…#Psychiatry#CME
🧠Psychiatry is changing—fast. From psychedelics to next-gen treatments, get the insights shaping real-world care.📍 mdsc.pe/4vH46Ag#PsychPharm26
Mental Health Awareness Month highlights that care goes beyond the physical. Let’s work toward “More Good Days, Together” by reducing stigma, encouraging dialogue, and helping patients access meaningful mental health support.
▶️ mdsc.pe/4euVVAQ
New learning available: Improve functional recovery in MDD by mastering rapid acting agents—understand novel MoAs, identify candidates for fast relief, and implement validated assessments for symptoms like anhedonia.
▶️ mdsc.pe/42wrW4p
đź’¬ Bring your toughest cases
Get real answers from experts tackling complex psychiatric conditions
👉 Ask what matters 🔗 mdsc.pe/41GEJRd#PsychPharm26